These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24434721)

  • 1. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
    Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
    Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population.
    Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH
    J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
    Kwon KH; Lee YC; Chung JH; Eun YG
    J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
    Eun YG; Kim SK; Chung JH; Kwon KH
    Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
    Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
    Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
    Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
    Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
    Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
    J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 22 polymorphisms and papillary thyroid cancer.
    Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
    J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
    Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
    Zhu J; Qi P; Li Z
    Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
    Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
    Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
    Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
    Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
    Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.